1	Completion of UX007G-CL201 study NCT 01993186 in the past 3 months patients who received UX007/triheptanoin treatment as apart of clinical studies ISTs or expanded access/compassionate use treatment programs may be eligible at the discretion of the Sponsor|triheptanoin[95,107]|||||||3 months[58,66]|||1313234|1313234|triheptanoin
